GENETIC ANOMALIES OF C4,CR1 & FCGR IN JUVENILE IGA-N
GENETIC ANOMALIES OF C4,CR1 & FCGR IN JUVENILE IGA-N
批准号:
2150047
负责人:
LEE A. HEBERT
金额:
$20.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 1998-08-31
关键词:
IgA nephropathy adult human (21+) age difference antibody receptor biopsy child (0-11) complement complement receptor gene mutation gene rearrangement glomerulonephritis human subject immune complex immunofluorescence technique immunoglobulin A molecular pathology polymerase chain reaction protein sequence southern blotting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This work will test the hypotheses that: 1) Abnormalities in complement
and/or FcR mechanisms for processing and clearing circulating. immune
complexes (lC) are often present in lgA nephritis (lgA-N) and, 2) The
extent of these abnormalities can determine whether the patient will
experience juvenile or adult-onset lgA-N. The concept that abnormalities
in lC processing and clearance can contribute to the development of lgA-N
is based in part on the well described association of lgA-N with
deficiencies of complement components and regulators that result in
impaired C3b generation. Impaired C3b generation is thought to predispose
to lC disease because of abnormal lC processing and clearance. Thus,
deficient or dysfunctional proteins involved in lC processing or clearing,
could play a role in the pathogenesis of lgA-N. Previous studies have not
critically tested this hypothesis. The concept that abnormalities in lC
processing and Clearance can predispose to juvenile-onset lgA-N is
speculative. However, as discussed herein, it is likely that the induction
of lgA-N requires the concurrence of various combinations of abnormalities
including abnormal production of lgA, production of abnormal lgA, and
abnormal lC processing and clearance. We suggest that, the greater the
number of such abnormalities, the earlier might be the age of onset of lgA-
N. To search for abnormalities in lC processing and clearance, we will
analyze both genomic DNA and cDNA of key proteins of the lC processing an
clearance mechanism. The goal is to determine whether there are allelic
differences or differences in the primary structure (amino acid sequence)
of key proteins involved in lC processing and clearance that can
distinguish lgA-N patients from normals, or adult-onset lgA-N from
juvenile-onset lgA-N. Such differences would define risk factors for lgA-N.
The mechanism of that risk would then need to be determined. The power of
the present approach is that defining alleles, or proteins at the amino
acid level, can reveal critical differences between proteins that can not
be revealed by analyses of the intact proteins. The key components of the
lC processing and clearing mechanisms chosen for study are the fourth
component of complement (C4), complement receptor Type 1 (CR1) that is
expressed on erythrocytes (E), and FcgammaRII. These components were
chosen because of evidence from previous studies that deficient amounts of
these proteins can be associated with lgA-N (C4 and E-CR1) or, in the case
of FcgammaRII, that certain isoforms are strongly associated with IC-
mediated glomerulonephritis of SLE. FcgammaRII is relevant because in lgA-
N, circulating lC and glomerular lC deposits often contain IgG. Previous
studies assessing lC clearance in lgA-N used preformed lC probes infused
intravenously. These lC probes are probably not suitable surrogates for
pathogenic circulating lC, as discussed herein. Thus, such studies cannot
be regarded as a critical test of the role of lC processing and clearance
in lgA-N. We have large cohorts to study: 35 juvenile-onset (age < 16
years), and 105 adult-onset (median age 37 years) lgA-N patients. Controls
will be 35 unaffected siblings of lgA-N patients, and 35 unrelated normals.
In summary, the present study will provide a genetic characterization of
key components of the lC processing and clearing mechanisms in lgA-N
compared to normals. More importantly the present study represents a novel
and more definitive approach to the search for abnormalities in lC
Processing and clearance in IgaA-N. and whether such abnormalities might
be determinants of juvenile onset IgA-N.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1681/asn.v104833
发表时间:
1999-04
期刊:
Journal of the American Society of Nephrology : JASN
影响因子:
--
作者:
[M. Dooley;F. Cosio;P. Nachman;M. Falkenhain;S. Hogan;R. Falk;L. Hebert]
通讯作者:
M. Dooley;F. Cosio;P. Nachman;M. Falkenhain;S. Hogan;R. Falk;L. Hebert
Effects of immune complex formation and complement activation on circulating platelets in the primate.
免疫复合物形成和补体激活对灵长类动物循环血小板的影响。
DOI:
10.1006/clim.1998.4677
发表时间:
1999
期刊:
Clinical immunology (Orlando, Fla.)
影响因子:
--
作者:
[Birmingham,DJ, Hebert,LA, Shen,XP, Higgins,P, Yeh,CG, Creasey,AA]
通讯作者:
Creasey,AA
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS
-
批准号:7625430
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2007
-
负责人:LEE A. HEBERT
-
依托单位:
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS
-
批准号:7718613
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2007
-
负责人:LEE A. HEBERT
-
依托单位:
OHIO SLE STUDY LONGITUDINAL STUDY
-
批准号:7374576
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2005
-
负责人:LEE A. HEBERT
-
依托单位:
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS
-
批准号:7374573
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2005
-
负责人:LEE A. HEBERT
-
依托单位:
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS
-
批准号:7198622
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2004
-
负责人:LEE A. HEBERT
-
依托单位:
OHIO SLE STUDY LONGITUDINAL STUDY
-
批准号:7198625
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2004
-
负责人:LEE A. HEBERT
-
依托单位:
Ohio SLE Study Longitudinal Study
-
批准号:7011507
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2003
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & clinical risk factors for human SLE nephritis
-
批准号:7011504
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2003
-
负责人:LEE A. HEBERT
-
依托单位:
Core--Coordination
-
批准号:6570869
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2002
-
负责人:LEE A. HEBERT
-
依托单位:
Pathogenesis of SLE relapse in humans
-
批准号:6570868
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2002
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:6517579
-
项目类别:
-
资助金额:$89.79万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:6333275
-
项目类别:
-
资助金额:$89.21万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:6844856
-
项目类别:
-
资助金额:$97.46万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:6635143
-
项目类别:
-
资助金额:$92.94万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:6729987
-
项目类别:
-
资助金额:$95.02万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:7280257
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
Genetic & Clinical Risk for Human SLE Nephritis
-
批准号:7498764
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2001
-
负责人:LEE A. HEBERT
-
依托单位:
GENETIC ANOMALIES OF C4, CR1 & FCYR JUVENILE IGA NEPHRITIS
-
批准号:6418835
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2000
-
负责人:LEE A. HEBERT
-
依托单位:
OHIO STATE UNIVERSITY APPLICATION TO AASK
-
批准号:6131536
-
项目类别:
-
资助金额:$6.17万
-
财政年份:1999
-
负责人:LEE A. HEBERT
-
依托单位:
GENETIC ANOMALIES OF C4, CR1 & FCYR JUVENILE IGA NEPHRITIS
-
批准号:6303085
-
项目类别:
-
资助金额:$4.86万
-
财政年份:1999
-
负责人:LEE A. HEBERT
-
依托单位: